Enhanced white adipose tissue metabolism in iatrogenic Cushing's syndrome with FDG PET/CT

Related Experiment Video

Updated: May 3, 2026

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
08:31

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Published on: July 1, 2021

2.6K

David A Pattison1, Michael S Hofman, Eddie Lau

  • 1Centre for Cancer Imaging (D.A.P., M.S.H., E.L., R.W., R.J.H.), and Endocrinology Service (D.A.P.), Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia; and Departments of Medicine (M.S.H., R.J.H.) and Radiology (E.L., R.J.H.), University of Melbourne, Melbourne, VIC 3010, Australia.

The Journal of Clinical Endocrinology and Metabolism
|February 18, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT
10:30

Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT

Published on: April 1, 2019

10.5K
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
10:53

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

18.8K

Related Experiment Videos

Last Updated: May 3, 2026

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
08:31

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Published on: July 1, 2021

2.6K
Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT
10:30

Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT

Published on: April 1, 2019

10.5K
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
10:53

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

18.8K

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

36
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
36
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24

Articles linked to this work by shared authors, journal, and citation graph.

A Practical Guide to Somatostatin Receptor Imaging with PET/Computed Tomography.

Radiologic clinics of North America·2026

Management of Patients with High-risk Localised, Locally Advanced, and Biochemically Recurrent Prostate Cancer: Report from the 2026 Advanced Prostate Cancer Consensus Conference.

European urology·2026

TheraPb Phase 1b: First-in-Human Dose-Escalation and Optimization Study of 212Pb-ADVC001 in PSMA-Positive Metastatic Androgen Pathway Modulation-Resistant Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Kidney impairment post 177Lu-PSMA radioligand therapy in metastatic prostate cancer.

Nuclear medicine communications·2026

Pivotal Phase 3 Theranostic Trials: Future Indications.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Efficacy and safety of sunitinib in treatment of advanced or metastatic pheochromocytomas and paragangliomas: A meta-analysis of sunitinib-treated arms from prospective clinical trials.

The Journal of clinical endocrinology and metabolism·2026

Glycemic And Patient-Reported Outcomes After Transition To Advanced Hybrid Closed-Loop System In Patients After Total Pancreatectomy.

The Journal of clinical endocrinology and metabolism·2026

Somapacitan Treatment in Children and Adolescents Born SGA: Two-Year Efficacy and Preference Over Daily GH.

The Journal of clinical endocrinology and metabolism·2026

Normal-BMI MASLD is Associated with Increased Mortality, Cardiovascular Events, Cancer and Lower GLP-1 Use.

The Journal of clinical endocrinology and metabolism·2026

Collagen VI-derived endotrophin impairs adipocyte function and insulin action in human obesity.

The Journal of clinical endocrinology and metabolism·2026

Would Artificial Intelligence Make 'Good' Decisions About Thyroid Nodule Biopsies?

The Journal of clinical endocrinology and metabolism·2026

Safety evaluation of an extension of use of the food enzyme lysophospholipase from the genetically modified Aspergillus niger strain NZYM-LP.

EFSA journal. European Food Safety Authority·2026

A facet joint landmark-guided approach for multi-segmental DRG injection with limited bone removal in mice.

Frontiers in neurology·2026

Responses of Glossina pallidipes tsetse fly to geosmin, 2-pentanol and carbon dioxide odour cues.

Royal Society open science·2026

Construction of Multigene-Deletion Vibrio parahaemolyticus Strains and Preliminary Evaluation of Their Short-Term Protective Effects in Litopenaeus vannamei.

Fish & shellfish immunology·2026

Algal Biomass and Algal-Derived Preparations in Livestock Nutrition: Gut Microbiota Modulation, Host Molecular Pathways, and Bioprocess Innovations.

Veterinary sciences·2026

Immunogenicity and Protective Efficacy of a Trivalent Whole-Virion Inactivated SARS-CoV-2 Vaccine Against Vaccine-Matched Ancestral, Delta, and Omicron BA.5 Variants in K18-hACE2 Mice.

Viruses·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us